Related Experiment Video

Updated: May 8, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

Feline CKD: New horizons - where do we go from here?

Samantha Taylor1, Andrew H Sparkes

  • 1International Society of Feline Medicine, High Street, Tisbury, Wiltshire SP3 6LD, UK.

Journal of Feline Medicine and Surgery
|September 4, 2013
PubMed

Insights

Future feline chronic kidney disease (CKD) treatments should delay progression and manage signs effectively. Research is needed to find easy, cost-effective interventions for feline CKD management.

Area of Science:

  • Veterinary Medicine
  • Nephrology

Background:

  • Chronic kidney disease (CKD) is a prevalent condition in cats, mirroring its significance in human health.
  • Current feline CKD management faces challenges due to late diagnosis and limited ability to halt disease progression.
  • Developing novel, practical treatments is crucial for improving feline CKD outcomes.

Purpose of the Study:

  • To explore future treatment possibilities for feline chronic kidney disease (CKD).
  • To identify interventions that delay CKD progression and manage clinical signs in cats.
  • To address the need for easy-to-administer and cost-effective feline CKD therapies.

Main Methods:

  • Reviewing large-scale human CKD studies for comparative insights.
  • Analyzing existing feline CKD treatment and prognosis research.
  • Highlighting the need for large-scale feline studies on specific drug classes.

Main Results:

  • Human medical research provides a foundation for understanding CKD treatment.
  • Existing feline studies offer partial insights but lack large-scale evidence.
  • Specific treatments like ACE inhibitors require further large-scale investigation in cats.

Conclusions:

  • Effective, accessible, and affordable treatments are essential for feline CKD management.
  • Further large-scale research is necessary to validate novel therapeutic approaches in cats.
  • Learning from human medical advancements can guide future feline CKD interventions.
Abstract

More Related Videos

Spectral Karyotyping to Study Chromosome Abnormalities in Humans and Mice with Polycystic Kidney Disease12:47

Spectral Karyotyping to Study Chromosome Abnormalities in Humans and Mice with Polycystic Kidney Disease

Published on: February 3, 2012

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...